The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8969341, 92 ID: ALA3687315
PubChem CID: 78113953
Max Phase: Preclinical
Molecular Formula: C32H34Cl2N4O3
Molecular Weight: 593.55
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1OCCN(C)C)C2=O
Standard InChI: InChI=1S/C32H34Cl2N4O3/c1-19(2)30-28-29(35-38(30)24-9-7-8-10-26(24)40-6)32(39)37(31(28)23-13-11-21(33)17-20(23)3)25-18-22(34)12-14-27(25)41-16-15-36(4)5/h7-14,17-19,31H,15-16H2,1-6H3
Standard InChI Key: YBMQYNARIZUNIO-UHFFFAOYSA-N
Molfile:
RDKit 2D
41 45 0 0 0 0 0 0 0 0999 V2000
5.0390 -0.8459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8395 -0.8809 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1265 -2.2016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9144 -3.4780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2029 -4.7985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7035 -4.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9157 -3.5662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6321 -2.2464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7500 -1.0323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2135 0.3943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.2760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4623 2.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2432 3.6715 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.9623 2.7008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4258 1.2743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8530 0.8102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0487 -0.6787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4362 -1.2487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.6235 -0.3321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7335 -0.7880 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-6.4234 1.1545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0359 1.7245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8754 2.9137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2135 0.3943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7500 -1.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6281 -2.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1385 -3.3418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8218 -2.1229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8444 3.9150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3210 3.6414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2915 4.7851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4721 4.5702 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-4.7863 6.1975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3105 6.4661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3400 5.3223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8636 5.5924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3584 7.0056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1179 7.2756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6232 8.6888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8036 8.9047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8463 9.6034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
19 21 1 0
21 22 2 0
22 16 1 0
22 23 1 0
15 24 1 0
24 11 1 0
24 25 2 0
25 9 1 0
25 26 1 0
26 27 1 0
26 28 1 0
14 29 1 0
29 30 2 0
30 31 1 0
31 32 1 0
31 33 2 0
33 34 1 0
34 35 2 0
35 29 1 0
35 36 1 0
36 37 1 0
37 38 1 0
38 39 1 0
39 40 1 0
39 41 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 593.55Molecular Weight (Monoisotopic): 592.2008AlogP: 7.31#Rotatable Bonds: 9Polar Surface Area: 59.83Molecular Species: BASEHBA: 6HBD: ┄#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.38CX Basic pKa: 8.70CX LogP: 7.45CX LogD: 6.13Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.20Np Likeness Score: -0.99
References 1. (2015) Pyrazolopyrrolidine compounds, 2. Furet P, Masuya K, Kallen J, Stachyra-Valat T, Ruetz S, Guagnano V, Holzer P, Mah R, Stutz S, Vaupel A, Chène P, Jeay S, Schlapbach A.. (2016) Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument., 26 (19): [PMID:27542305 ] [10.1016/j.bmcl.2016.08.010 ]